Allen A. Fienberg
Corporate Officer/Principal bij ITI, Inc. (New York)
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Sharon Mates | M | 71 |
Intra-Cellular Therapies, Inc. /Old/
Intra-Cellular Therapies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company which focuses on the discovery and clinical development of innovative, small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system. The company's technology addresses diseases of the central nervous system, including schizophrenia, cognition, Parkinson's disease, anxiety, depression, Alzheimer's disease, sleep, and those related to women's health. Its products include clinical development plan for schizophrenia and unique mechanism of action. Intra-Cellular Therapies was founded by Paul Greengard, Sharon Mates and Allen A. Fienberg on May 22, 2001 and is headquartered in New York, NY.
ITI, Inc. (New York)
| 22 jaar |
Lawrence Hineline | M | 67 |
Intra-Cellular Therapies, Inc. /Old/
Intra-Cellular Therapies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company which focuses on the discovery and clinical development of innovative, small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system. The company's technology addresses diseases of the central nervous system, including schizophrenia, cognition, Parkinson's disease, anxiety, depression, Alzheimer's disease, sleep, and those related to women's health. Its products include clinical development plan for schizophrenia and unique mechanism of action. Intra-Cellular Therapies was founded by Paul Greengard, Sharon Mates and Allen A. Fienberg on May 22, 2001 and is headquartered in New York, NY.
ITI, Inc. (New York)
| 22 jaar |
Michael Rawlins | M | 82 |
Intra-Cellular Therapies, Inc. /Old/
Intra-Cellular Therapies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company which focuses on the discovery and clinical development of innovative, small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system. The company's technology addresses diseases of the central nervous system, including schizophrenia, cognition, Parkinson's disease, anxiety, depression, Alzheimer's disease, sleep, and those related to women's health. Its products include clinical development plan for schizophrenia and unique mechanism of action. Intra-Cellular Therapies was founded by Paul Greengard, Sharon Mates and Allen A. Fienberg on May 22, 2001 and is headquartered in New York, NY.
ITI, Inc. (New York)
| 1 jaar |
Chris D. Alafi | M | 60 |
Intra-Cellular Therapies, Inc. /Old/
Intra-Cellular Therapies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company which focuses on the discovery and clinical development of innovative, small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system. The company's technology addresses diseases of the central nervous system, including schizophrenia, cognition, Parkinson's disease, anxiety, depression, Alzheimer's disease, sleep, and those related to women's health. Its products include clinical development plan for schizophrenia and unique mechanism of action. Intra-Cellular Therapies was founded by Paul Greengard, Sharon Mates and Allen A. Fienberg on May 22, 2001 and is headquartered in New York, NY.
ITI, Inc. (New York)
| 11 jaar |
Lawrence P. Wennogle | M | 74 |
Intra-Cellular Therapies, Inc. /Old/
Intra-Cellular Therapies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company which focuses on the discovery and clinical development of innovative, small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system. The company's technology addresses diseases of the central nervous system, including schizophrenia, cognition, Parkinson's disease, anxiety, depression, Alzheimer's disease, sleep, and those related to women's health. Its products include clinical development plan for schizophrenia and unique mechanism of action. Intra-Cellular Therapies was founded by Paul Greengard, Sharon Mates and Allen A. Fienberg on May 22, 2001 and is headquartered in New York, NY.
ITI, Inc. (New York)
| 11 jaar |
Kimberly E. Vanover | M | 58 |
Intra-Cellular Therapies, Inc. /Old/
Intra-Cellular Therapies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company which focuses on the discovery and clinical development of innovative, small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system. The company's technology addresses diseases of the central nervous system, including schizophrenia, cognition, Parkinson's disease, anxiety, depression, Alzheimer's disease, sleep, and those related to women's health. Its products include clinical development plan for schizophrenia and unique mechanism of action. Intra-Cellular Therapies was founded by Paul Greengard, Sharon Mates and Allen A. Fienberg on May 22, 2001 and is headquartered in New York, NY.
ITI, Inc. (New York)
| 7 jaar |
Rory Riggs | M | 71 |
ITI, Inc. (New York)
| 10 jaar |
Joel Marcus | M | 76 |
ITI, Inc. (New York)
| 18 jaar |
Robert van Nostrand | M | 67 |
ITI, Inc. (New York)
| 10 jaar |
Michael Halstead | M | 51 |
ITI, Inc. (New York)
| 10 jaar |
Peter N. Herbert | M | - |
Yale University
| 33 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Shakil Waiz Ahmed | M | - |
Yale University
| 6 jaar |
George John Melas-Kyriazi | M | - |
Yale University
| 4 jaar |
Richard Alan Lerner | M | 85 |
Intra-Cellular Therapies, Inc. /Old/
Intra-Cellular Therapies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company which focuses on the discovery and clinical development of innovative, small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system. The company's technology addresses diseases of the central nervous system, including schizophrenia, cognition, Parkinson's disease, anxiety, depression, Alzheimer's disease, sleep, and those related to women's health. Its products include clinical development plan for schizophrenia and unique mechanism of action. Intra-Cellular Therapies was founded by Paul Greengard, Sharon Mates and Allen A. Fienberg on May 22, 2001 and is headquartered in New York, NY. | 11 jaar |
Jae-Chun Kim | M | 59 |
Yale University
| 2 jaar |
Joseph Patt | M | - |
Yale University
| 4 jaar |
Grady S. Vanderhoofven | M | - |
Yale University
| 4 jaar |
Aaron Kaslow | M | 59 |
Yale University
| 7 jaar |
Ranjan Goswami | M | - |
Yale University
| 14 jaar |
Patrick Ennis | M | 61 |
Yale University
| 6 jaar |
Maxine Williams | F | 53 |
Yale University
| 4 jaar |
Samrat Ganguly | M | - |
Yale University
| 4 jaar |
Matthew Barney | M | 57 |
Yale University
| 4 jaar |
Andrew Singer | M | 53 |
Yale University
| 4 jaar |
Gang-Shik Choi | M | 64 |
Yale University
| 3 jaar |
Clyde Tuggle | M | 63 |
Yale University
| 3 jaar |
Veronica Wu | M | 53 |
Yale University
| 4 jaar |
Simon Duxbury | M | - |
Yale University
| 4 jaar |
Neil M. Hohmann | M | - |
Yale University
| 4 jaar |
Andrew Evan Wolff | M | 55 |
Yale University
| 4 jaar |
Petru Ion Vãduva | M | 64 |
Yale University
| 2 jaar |
Robert Harding | M | - |
Yale University
| 4 jaar |
Andrew E. Wolff | M | 55 |
Yale University
| 4 jaar |
Jack Taylor Thompson | M | 52 |
Yale University
| 4 jaar |
Dwight S. Yoo | M | - |
Yale University
| 4 jaar |
Kevin DeLeon | M | 56 |
Yale University
| 4 jaar |
Beth Birnbaum | F | 51 |
Yale University
| 4 jaar |
Jay Readey | M | - |
Yale University
| 4 jaar |
Stephen Griesemer | M | - |
Yale University
| 4 jaar |
Emily Dougherty | F | - |
Yale University
| 4 jaar |
Manish Shah | M | - |
Yale University
| 4 jaar |
Kristin Kyoko Altman | F | 56 |
Yale University
| 4 jaar |
Alexander Sion | M | - |
Yale University
| 4 jaar |
Nell Breyer | F | - |
Yale University
| 4 jaar |
Marisa Grant | F | - |
Yale University
| 4 jaar |
Matt Mochary | M | - |
Yale University
| 4 jaar |
Ted Hillenmeyer | M | - |
Yale University
| 4 jaar |
Adam Kaplin | M | 57 |
Yale University
| 4 jaar |
David Schwimmer | M | 55 |
Yale University
| 4 jaar |
Joseph M. Passero | M | 55 |
Yale University
| 4 jaar |
Byron Auguste | M | 56 |
Yale University
| 4 jaar |
Leslie Goldman | F | - |
Yale University
| 4 jaar |
Lin Zhou | M | 64 |
Yale University
| 7 jaar |
David Rubin | M | - |
Yale University
| 4 jaar |
Calvin Chin | M | - |
Yale University
| 4 jaar |
James O'Neill | M | 59 |
Yale University
| 4 jaar |
Chris Rossbach | M | 54 |
Yale University
| 4 jaar |
Vic Myer | M | - |
Yale University
| 6 jaar |
Erin M. Duffy | M | 55 |
Yale University
| 3 jaar |
Chester A. Metcalf | M | - |
Yale University
| 3 jaar |
Ping Zhao | M | - |
Yale University
| 3 jaar |
Peter Beinart | M | - |
Yale University
| 4 jaar |
Gregory Flynn | M | 60 |
Yale University
| 1 jaar |
Umut Ergun | M | - |
Yale University
| 4 jaar |
Douglas A. Parker | M | - |
Yale University
| 4 jaar |
Mitchell S. Presser | M | 59 |
Yale University
| 3 jaar |
Nicholas G. Demmo | M | - |
Yale University
| 4 jaar |
Steven D. Lofchie | M | - |
Yale University
| 3 jaar |
Chris Gaughan | M | - |
Yale University
| 4 jaar |
Paul Lipari | M | 55 |
Yale University
| 4 jaar |
Peter Lyons Early | M | - |
Yale University
| 4 jaar |
Jack E. Plym | M | - |
Yale University
| 4 jaar |
Joshua Woolston Fenton | M | - |
Yale University
| 4 jaar |
Andy Toburen | M | 52 |
Yale University
| 4 jaar |
Justin Chang | M | 56 |
Yale University
| 4 jaar |
Keith Rosenbloom | M | 55 |
Yale University
| 4 jaar |
Louis Brenner | M | 54 |
Yale University
| 4 jaar |
Robert C. Bruce | M | 62 |
Yale University
| 2 jaar |
Ajit Nedungadi | M | 54 |
Yale University
| 4 jaar |
Philip J. Koh | M | - |
Yale University
| 4 jaar |
Bryan Ross Lawrence | M | - |
Yale University
| 4 jaar |
William Xin | M | 57 |
Yale University
| 4 jaar |
Katherine Roy | F | - |
Yale University
| 4 jaar |
Matthew W. Finlay | M | 57 |
Yale University
| 4 jaar |
Alexandre Emery | M | 53 |
Yale University
| 4 jaar |
Dennis Charney | M | 72 |
Yale University
| 10 jaar |
Timothy Lewis | M | - |
Yale University
| 4 jaar |
A. Breitenstein | F | 55 |
Yale University
| 4 jaar |
William J. Antholis | M | - |
Yale University
| 3 jaar |
David Ryan | M | 54 |
Yale University
| 4 jaar |
William J. Gumina | M | 53 |
Yale University
| 4 jaar |
Paul Budnitz | M | - |
Yale University
| 4 jaar |
Robert Auerbach | M | 64 |
Yale University
| - |
Amy Raimundo | F | 51 |
Yale University
| 4 jaar |
Plutarchos Sakellaris | M | 60 |
Yale University
| 3 jaar |
Hal Barron | M | 62 |
Yale University
| 3 jaar |
Robert Roman Lorenz | M | - |
Yale University
| 4 jaar |
Pawel Chudzicki | M | - |
Yale University
| 4 jaar |
Ken Everding | M | 62 |
Yale University
| 5 jaar |
Matthew Fassler | M | 53 |
Yale University
| 4 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigde Staten | 100 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Allen A. Fienberg
- Persoonlijk netwerk